|
| | | | | | | | | | |
| Name | Indication | Approved | Economics | | | | | Price JPY | 7534 |
| Leqembi (lecanemab) | Alzheimer's | 1/7/2023 | BIIB | | | | | Shares | 286.746 |
| Aricept (donepezil) | Alzheimer's | | | | | | | MC JPY | 2160344.364 |
| Metoject (methotrexate) | Rheumatoid Arthritis | | | | | | | Cash JPY | 313870 |
| Lenvima/Kisplyx (lenvatinib) | RCC | | MRK | | | | | Debt JPY | |
| Halaven (eribulin) | Breast Cancer | | | | | | | EV JPY | |
| Dayvigo (lemborexant | Insomnia | | | | | | | | |
| Humira (adalimumab) | Rheumatoid Arthritis | | ABBV | | | | | | |
| Methycobal | Neuropathy | | | | | | | | |
| Elental | Diet | | | | | | | | |
| Jyseleca | Rheumatoid Arthritis | | JAK | | | | | | |
| Goofice | Constipation | | | | | | | | |
| Pariet | GERD | | PPI | | | | | | |
| Movicol | Constipation | | | | | | | | |
| Fycompa (perampanel) | Epilepsy | | | | | | | | |
| | | | | | | | | | |
| E7386 | Oncology | | | | | | | | |
| farletuzumab ecteribulin | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | 12/23/22: Addresses lecanemab patient death report. | | | | | |
| | | | | 12/16/22: terminates ADR program | | | | | |
| | | | | 11/29/22: Addresses lecanemab patient death report. | | | | | |